Clinical Trial Update: A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind trial comparing paclitaxel with and without RAD001 in advanced gastric cancer after prior chemotherapy (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• RAD001 (everolimus)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Advanced Gastric Cancer, Esophagogastric Junction Cancer | Phase 3 | Status: COMPLETED